logo
Select company
Select metric
-32060.13%EBIT Margin
VS
Market
1
Sector
3
Industry
6
History
-
$ 2.29Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information

Ticker

SABS

Company Name

SAB BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAB BIOTHERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SABS - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -36.77M-32060.13%$ 114.7K
3/31/2025$ -33.96M-8989.31%$ 377.83K
12/31/2024$ -33.79M-2554.95%$ 1.32M
9/30/2024$ -45.24M-2990.76%$ 1.51M
6/30/2024$ -40M-1438.92%$ 2.78M
3/31/2024$ -39.57M-1520.34%$ 2.6M
12/31/2023$ -41.88M-1870.42%$ 2.24M
9/30/2023$ -26.86M-655.97%$ 4.09M
6/30/2023$ -28.83M-449.32%$ 6.42M
3/31/2023$ -26.83M-211.52%$ 12.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -27.68%.
  • Over the past 5 years, SAB BIOTHERAPEUTICS INC's average EBIT % has been -3782.67%.
  • The median EBIT % for SAB BIOTHERAPEUTICS INC during this period was -1047.44%
  • SAB BIOTHERAPEUTICS INC reached its highest EBIT % over the past 5 years at -27.68%.
  • The lowest EBIT % recorded by SAB BIOTHERAPEUTICS INC in the same timeframe -32060.13%

SAB BIOTHERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ABP : ABPRO HOLDINGS INC -6089.62%AIM : AIM IMMUNOTECH INC -12858.68%AIMD : AINOS INC -13453.71%PFSA : PROFUSA INC -13313.21%KAPA : KAIROS PHARMA LTD -PPCB : PROPANC BIOPHARMA INC -QTTB : Q32 BIO INC -CVKD : CADRENAL THERAPEUTICS INC -VIVS : VIVOSIM LABS INC -1389.44%LIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for SAB BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ -16.85M ] / Revenues [ $ 60.88M ]
(=) EBIT % [ -27.68% ]

SABS - EBIT Margin, Last 5 years

-32060.13%

Minimum

Jun 30, 2025

-27.68%

Maximum

Dec 31, 2021

-3782.67%

Average

-1047.44%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%